193 related articles for article (PubMed ID: 14749923)
1. Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Vicentini C; Gravina GL; Angelucci A; Pascale E; D'Ambrosio E; Muzi P; Di Leonardo G; Fileni A; Tubaro A; Festuccia C; Bologna M
J Cancer Res Clin Oncol; 2004 Apr; 130(4):217-21. PubMed ID: 14749923
[TBL] [Abstract][Full Text] [Related]
2. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in needle biopsies from prostate cancer and benign prostates.
Wymenga LF; Wisman GB; Veenstra R; Ruiters MH; Mensink HJ
Eur J Clin Invest; 2000 Apr; 30(4):330-5. PubMed ID: 10759882
[TBL] [Abstract][Full Text] [Related]
4. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
[TBL] [Abstract][Full Text] [Related]
6. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
7. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
8. An appraisal of telomerase activity in benign prostatic hyperplasia.
Caldarera E; Crooks NH; Muir GH; Pavone-Macaluso M; Carmichael PL
Prostate; 2000 Nov; 45(3):267-70. PubMed ID: 11074530
[TBL] [Abstract][Full Text] [Related]
9. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
[TBL] [Abstract][Full Text] [Related]
10. Development of an ELISA for sPSP94 and utility of the sPSP94/sPSA ratio as a diagnostic indicator to differentiate between benign prostatic hyperplasia and prostate cancer.
Mhatre DR; Mahale SD; Khatkhatay MI; Desai SS; Jagtap DD; Dhabalia JV; Tongaonkar HB; Desai MP; Dandekar SP; Varadkar AM
Clin Chim Acta; 2014 Sep; 436():256-62. PubMed ID: 24952364
[TBL] [Abstract][Full Text] [Related]
11. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?
Scates DK; Muir GH; Venitt S; Carmichael PL
Br J Urol; 1997 Aug; 80(2):263-8. PubMed ID: 9284200
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of PSAD and PSAD-TZ value in prostatic hyperplasia and prostatic cancer].
Fu Q; Yao DH; Jiang YQ
Zhonghua Nan Ke Xue; 2002 Dec; 8(6):411-3. PubMed ID: 12593013
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Zhang W; Kapusta LR; Slingerland JM; Klotz LH
Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
[TBL] [Abstract][Full Text] [Related]
14. [Free/total prostate specific antigen ratio (%PSA) to predict probability of prostate cancer].
Zenimoto M; Kita M; Arai T; Murayama T; Mori M
Rinsho Byori; 2003 Oct; 51(10):969-73. PubMed ID: 14653195
[TBL] [Abstract][Full Text] [Related]
15. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens.
Wang Z; Ramin SA; Tsai C; Lui P; Ruckle HC; Beltz RE; Sands JF; Slattery CW
Urol Oncol; 2002; 7(5):199-205. PubMed ID: 12644217
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
19. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
20. Focal intratumoral heterogeneity for telomerase activity in human prostate cancer.
Wullich B; Rohde V; Oehlenschläger B; Bonkhoff H; Ketter R; Zwergel T; Sattler HP
J Urol; 1999 Jun; 161(6):1997-2001. PubMed ID: 10332489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
